companydata.dkcompanydata.dk

ZP SPV 3 K/S: Financial statements 2022

CVR: 41038039

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

ZP SPV 3 K/S (CVR 41038039) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 37,755,000 and a net result of DKK -1,791,000 compared with USD 50,000 the year before. That is an increase of 2,245% compared with the year before. The profit margin was -4.7%. Equity in the 2022 report amounted to DKK 35,174,000. The solvency ratio was 91.4%.

Revenue
DKK 37,755,000
Gross Profit
DKK 37,755,000
Profit/Loss
DKK -1,791,000
Equity
DKK 35,174,000
Total Assets
DKK 38,491,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202237.8M37.8M-1.8M35.2M-
20211.6M USD1.6M USD50K USD5.6M USD-
20201K USD1K USD-118 USD6K USD-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on ZP SPV 3 K/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

ZP SPV 3 K/S: The 2021 annual report is outJul 6, 2022

ZP SPV 3 K/S has published its annual report for 2021. Revenue came to DKK 1,610,000, and the net result was DKK 50,000.

About ZP SPV 3 K/S

ZP SPV 3 K/S is a Danish company of the type Kommanditselskab based in Søborg, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of ZP General Partner 3 ApS. The company is owned by ZEALAND PHARMA A/S. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -1,039,000 compared with DKK -34,739,000 the year before. Equity in the 2025 report amounted to DKK 429,000.

Source: annual report 2025, Danish Business Authority

Other financial years